Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial
Author:
Funder
French National Research Agency
Foundation Philanthropia Lombard Odier.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy
Link
http://link.springer.com/content/pdf/10.1186/s12913-017-2066-x.pdf
Reference60 articles.
1. Thanki K, Gangwal RP, Sangamwar AT, Jain S. Oral delivery of anticancer drugs: Challenges and opportunities. J Controlled Release. 2013;170:15–40.
2. Agboola S, Flanagan C, Searl M, Elfiky A, Kvedar J, Jethwani K. Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: study design of a randomized controlled trial. JMIR Res Protoc. 2014;3:e79.
3. Spoelstra SL, Given BA, Given CW, Grant M. Policy Implications of Oral Agents. Semin Oncol Nurs. 2011;27:161–5.
4. Spoelstra SL, Given CW. Assessment and Measurement of Adherence to Oral Antineoplastic Agents. Semin Oncol Nurs. 2011;27:116–32.
5. Spoelstra SL, Given BA, Given CW, Grant M, Sikorskii A, You M, et al. An Intervention to Improve Adherence and Management of Symptoms for Patients Prescribed Oral Chemotherapy Agents: An Exploratory Study. Cancer Nurs. 2013;36:18–28.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Perspectives on seamless collaboration between primary and secondary care for oral anticancer treatments;Journal of Interprofessional Care;2023-01-04
2. The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis;European Journal of Cancer Care;2022-09-27
3. Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial;Nature Medicine;2022-04-25
4. The effect of navigation programme on the management of symptoms related to head and neck radiotherapy;Transplant Immunology;2021-12
5. Cost-effectiveness of patient navigation for lung cancer – a systematic review;F1000Research;2021-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3